{
    "indexed": {
        "date-parts": [
            [
                2022,
                7,
                30
            ]
        ],
        "date-time": "2022-07-30T07:07:15Z",
        "timestamp": 1659164835124
    },
    "reference-count": 59,
    "publisher": "Oxford University Press (OUP)",
    "issue": "2",
    "license": [
        {
            "start": {
                "date-parts": [
                    [
                        2021,
                        3,
                        18
                    ]
                ],
                "date-time": "2021-03-18T00:00:00Z",
                "timestamp": 1616025600000
            },
            "content-version": "vor",
            "delay-in-days": 0,
            "URL": "https://creativecommons.org/licenses/by/4.0/"
        }
    ],
    "content-domain": {
        "domain": [],
        "crossmark-restriction": false
    },
    "short-container-title": [],
    "published-print": {
        "date-parts": [
            [
                2022,
                1,
                18
            ]
        ]
    },
    "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>We provide evidence that risk aversion leads pharmaceutical firms to underinvest in radical innovation. We introduce a new measure of drug novelty based on chemical similarity and show that firms face a risk-reward trade-off: novel drug candidates are less likely to obtain FDA approval but are based on more valuable patents. Consistent with a simple model of costly external finance, we show that a positive shock to firms\u2019 net worth leads firms to develop more novel drugs. This suggests that even large firms may behave as though they are risk averse, reducing their willingness to investment in potentially valuable radical innovation.</jats:p>",
    "DOI": "10.1093/rfs/hhab024",
    "type": "journal-article",
    "created": {
        "date-parts": [
            [
                2021,
                3,
                15
            ]
        ],
        "date-time": "2021-03-15T12:10:09Z",
        "timestamp": 1615810209000
    },
    "page": "636-679",
    "source": "Crossref",
    "is-referenced-by-count": 6,
    "title": [
        "Missing Novelty in Drug Development"
    ],
    "prefix": "10.1093",
    "volume": "35",
    "author": [
        {
            "given": "Joshua",
            "family": "Krieger",
            "sequence": "first",
            "affiliation": []
        },
        {
            "given": "Danielle",
            "family": "Li",
            "sequence": "additional",
            "affiliation": []
        },
        {
            "given": "Dimitris",
            "family": "Papanikolaou",
            "sequence": "additional",
            "affiliation": []
        }
    ],
    "member": "286",
    "published-online": {
        "date-parts": [
            [
                2021,
                3,
                18
            ]
        ]
    },
    "reference": [
        {
            "key": "2022011810042072100_B1",
            "volume-title": "What\u2019s the value of patent citations? Evidence from pharmaceuticals",
            "author": "Abrams,",
            "year": "2017"
        },
        {
            "key": "2022011810042072100_B2",
            "doi-asserted-by": "crossref",
            "first-page": "1049",
            "DOI": "10.1162/0033553041502144",
            "article-title": "Market size in innovation: Theory and evidence from the pharmaceutical industry",
            "volume": "119",
            "author": "Acemoglu,",
            "year": "2004",
            "journal-title": "Quarterly Journal of Economics"
        },
        {
            "key": "2022011810042072100_B3",
            "first-page": "223",
            "article-title": "Financial dependence and innovation: The case of public versus private firms",
            "volume": "124",
            "author": "Acharya,",
            "year": "2017"
        },
        {
            "key": "2022011810042072100_B4",
            "doi-asserted-by": "crossref",
            "first-page": "1374",
            "DOI": "10.1086/697901",
            "article-title": "Growth through heterogeneous innovations",
            "volume": "126",
            "author": "Akcigit,",
            "year": "2018",
            "journal-title": "Journal of Political Economy"
        },
        {
            "key": "2022011810042072100_B5",
            "doi-asserted-by": "crossref",
            "first-page": "3",
            "DOI": "10.1561/104.00000001",
            "article-title": "Corporate debt maturity and the real effects of the 2007 credit crisis",
            "volume": "1",
            "author": "Almeida,",
            "year": "2011",
            "journal-title": "Critical Finance Review"
        },
        {
            "key": "2022011810042072100_B6",
            "article-title": "Big pharma, bad medicine",
            "volume-title": "Boston Review",
            "author": "Angell,",
            "year": "2010"
        },
        {
            "key": "2022011810042072100_B7",
            "doi-asserted-by": "crossref",
            "first-page": "609",
            "volume-title": "The rate and direction of inventive activity: economic and social factors",
            "author": "Arrow,",
            "year": "1962",
            "DOI": "10.1515/9781400879762-024"
        },
        {
            "key": "2022011810042072100_B8",
            "doi-asserted-by": "crossref",
            "first-page": "117",
            "DOI": "10.1093/restud/rdy034",
            "article-title": "Public r&d investments and private-sector patenting: Evidence from nih funding rules",
            "volume": "86",
            "author": "Azoulay,",
            "year": "2019",
            "journal-title": "Review of Economic Studies"
        },
        {
            "key": "2022011810042072100_B9",
            "doi-asserted-by": "crossref",
            "first-page": "1205",
            "DOI": "10.1021/ci100010v",
            "article-title": "When is chemical similarity significant? the statistical distribution of chemical similarity scores and its extreme values",
            "volume": "50",
            "author": "Baldi,",
            "year": "2010",
            "journal-title": "Journal of Chemical Information and Modeling"
        },
        {
            "key": "2022011810042072100_B10",
            "doi-asserted-by": "crossref",
            "first-page": "90",
            "DOI": "10.1038/nchem.1243",
            "article-title": "Quantifying the chemical beauty of drugs",
            "volume": "4",
            "author": "Bickerton,",
            "year": "2012",
            "journal-title": "Nature Chemistry"
        },
        {
            "key": "2022011810042072100_B11",
            "doi-asserted-by": "crossref",
            "first-page": "337",
            "DOI": "10.1016/0304-405X(94)90009-4",
            "article-title": "What do firms do with cash windfalls?",
            "volume": "36",
            "author": "Blanchard,",
            "year": "1994",
            "journal-title": "Journal of Financial Economics"
        },
        {
            "key": "2022011810042072100_B12",
            "doi-asserted-by": "crossref",
            "first-page": "327",
            "DOI": "10.1016/j.jpubeco.2012.10.003",
            "article-title": "Market size and innovation: Effects of medicare part d on pharmaceutical research and development",
            "volume": "97",
            "author": "Blume-Kohout,",
            "year": "2013",
            "journal-title": "Journal of Public Economics"
        },
        {
            "key": "2022011810042072100_B13",
            "doi-asserted-by": "crossref",
            "first-page": "1545",
            "DOI": "10.1111/j.1540-6261.2011.01681.x",
            "article-title": "A unified theory of tobin\u2019s $q$, corporate investment, financing, and risk management",
            "volume": "66",
            "author": "Bolton,",
            "year": "2011",
            "journal-title": "Journal of Finance"
        },
        {
            "key": "2022011810042072100_B14",
            "first-page": "433",
            "article-title": "Investment, r&d and financial constraints in britain and germany",
            "volume": "79",
            "author": "Bond,",
            "year": "2005",
            "journal-title": "Annals of Economics and Statistics"
        },
        {
            "key": "2022011810042072100_B15",
            "doi-asserted-by": "crossref",
            "first-page": "151",
            "DOI": "10.1111/j.1540-6261.2008.01431.x",
            "article-title": "Financing innovation and growth: Cash flow, external equity, and the 1990s r&d boom",
            "volume": "64",
            "author": "Brown,",
            "year": "2009",
            "journal-title": "Journal of Finance"
        },
        {
            "key": "2022011810042072100_B16",
            "doi-asserted-by": "crossref",
            "first-page": "2044",
            "DOI": "10.1257/aer.20131176",
            "article-title": "Do firms underinvest in long-term research? evidence from cancer clinical trials",
            "volume": "105",
            "author": "Budish,",
            "year": "2015",
            "journal-title": "American Economic Review"
        },
        {
            "key": "2022011810042072100_B17",
            "article-title": "AbbVie partners with Google\u2019s Calico on $\\$$1.5B R&D operation focused on aging",
            "volume-title": "Fierce Biotech",
            "author": "Carroll,",
            "year": "2014"
        },
        {
            "key": "2022011810042072100_B18",
            "doi-asserted-by": "crossref",
            "first-page": "1",
            "DOI": "10.1093/qje/qjt031",
            "article-title": "The employment effects of credit market disruptions: Firm-level evidence from the 2008-09 financial crisis",
            "volume": "129",
            "author": "Chodorow-Reich,",
            "year": "2014",
            "journal-title": "Quarterly Journal of Economics"
        },
        {
            "key": "2022011810042072100_B19",
            "doi-asserted-by": "crossref",
            "first-page": "2295",
            "DOI": "10.1111/j.1540-6261.2012.01787.x",
            "article-title": "Dynamic agency and the q theory of investment",
            "volume": "67",
            "author": "DeMarzo,",
            "year": "2012",
            "journal-title": "Journal of Finance"
        },
        {
            "key": "2022011810042072100_B20",
            "doi-asserted-by": "crossref",
            "first-page": "23",
            "DOI": "10.1038/nrd3296",
            "article-title": "Competitiveness in follow-on drug r&d: A race or imitation?",
            "volume": "10",
            "author": "DiMasi,",
            "year": "2010",
            "journal-title": "Nature Reviews Drug Discovery"
        },
        {
            "key": "2022011810042072100_B21",
            "doi-asserted-by": "crossref",
            "first-page": "23",
            "DOI": "10.1038/nrd3296",
            "article-title": "Competitiveness in follow-on drug r&d: a race or imitation?",
            "volume": "10",
            "author": "DiMasi,",
            "year": "2011",
            "journal-title": "Nature Reviews Drug Discovery"
        },
        {
            "key": "2022011810042072100_B22",
            "doi-asserted-by": "crossref",
            "first-page": "20",
            "DOI": "10.1016/j.jhealeco.2016.01.012",
            "article-title": "Innovation in the pharmaceutical industry: New estimates of r&d costs",
            "volume": "47",
            "author": "DiMasi,",
            "year": "2016",
            "journal-title": "Journal of Health Economics"
        },
        {
            "key": "2022011810042072100_B23",
            "doi-asserted-by": "crossref",
            "first-page": "1",
            "DOI": "10.2165/00019053-200422002-00002",
            "article-title": "The economics of follow-on drug research and development",
            "volume": "22",
            "author": "DiMasi,",
            "year": "2004",
            "journal-title": "PharmacoEconomics"
        },
        {
            "key": "2022011810042072100_B24",
            "volume-title": "Breakthrough or me-too? The impact of medicare part d on biotech innovation",
            "author": "Dranove,",
            "year": "2014"
        },
        {
            "key": "2022011810042072100_B25",
            "doi-asserted-by": "crossref",
            "first-page": "844",
            "DOI": "10.1111/1756-2171.12113",
            "article-title": "Market size and pharmaceutical innovation",
            "volume": "46",
            "author": "Dubois,",
            "year": "2015",
            "journal-title": "RAND Journal of Economics"
        },
        {
            "key": "2022011810042072100_B26",
            "doi-asserted-by": "crossref",
            "first-page": "590",
            "DOI": "10.1257/aer.100.1.590",
            "article-title": "The effect of medicare part d on pharmaceutical prices and utilization",
            "volume": "100",
            "author": "Duggan,",
            "year": "2010",
            "journal-title": "American Economic Review"
        },
        {
            "key": "2022011810042072100_B27",
            "doi-asserted-by": "crossref",
            "first-page": "89",
            "DOI": "10.1016/j.jmoneco.2014.12.011",
            "article-title": "Financing constraints and unemployment: Evidence from the Great Recession",
            "volume": "75",
            "author": "Duygan-Bump,",
            "year": "2015",
            "journal-title": "Journal of Monetary Economics"
        },
        {
            "key": "2022011810042072100_B28",
            "doi-asserted-by": "crossref",
            "first-page": "964",
            "DOI": "10.1038/nbt.2374",
            "article-title": "Commercializing biomedical research through securitization techniques",
            "volume": "30",
            "author": "Fernandez,",
            "year": "2012",
            "journal-title": "Nature Biotechnology"
        },
        {
            "key": "2022011810042072100_B29",
            "volume-title": "The incidence of the medicare prescription drug benefit: Using asset prices to assess its impact on drug makers",
            "author": "Friedman,",
            "year": "2009"
        },
        {
            "key": "2022011810042072100_B30",
            "doi-asserted-by": "crossref",
            "first-page": "1629",
            "DOI": "10.1111/j.1540-6261.1993.tb05123.x",
            "article-title": "Risk Management: Coordinating Corporate Investment and Financing Policies",
            "volume": "48",
            "author": "Froot,",
            "year": "1993",
            "journal-title": "Journal of Finance"
        },
        {
            "key": "2022011810042072100_B31",
            "doi-asserted-by": "crossref",
            "first-page": "902",
            "DOI": "10.1086/681575",
            "article-title": "Economic effects of runs on early \u201cshadow banks\u201d: Trust companies and the impact of the panic of 1907",
            "volume": "123",
            "author": "Frydman,",
            "year": "2015",
            "journal-title": "Journal of Political Economy"
        },
        {
            "key": "2022011810042072100_B32",
            "first-page": "16",
            "article-title": "Market value and patent citations",
            "volume": "36",
            "author": "Hall,",
            "year": "2005",
            "journal-title": "RAND Journal of Economics"
        },
        {
            "key": "2022011810042072100_B33",
            "doi-asserted-by": "crossref",
            "first-page": "609",
            "volume-title": "Handbook of the economics of innovation",
            "author": "Hall,",
            "year": "2010",
            "DOI": "10.1016/S0169-7218(10)01014-2"
        },
        {
            "key": "2022011810042072100_B34",
            "doi-asserted-by": "crossref",
            "first-page": "511",
            "DOI": "10.1162/003465399558265",
            "article-title": "Citation frequency and the value of patented inventions",
            "volume": "81",
            "author": "Harhoff,",
            "year": "1999",
            "journal-title": "Review of Economics and Statistics"
        },
        {
            "key": "2022011810042072100_B35",
            "doi-asserted-by": "crossref",
            "first-page": "32",
            "DOI": "10.2307/2555791",
            "article-title": "Scale, scope, and spillovers: The determinants of research productivity in drug discovery",
            "volume": "27",
            "author": "Henderson,",
            "year": "1996",
            "journal-title": "RAND Journal of Economics"
        },
        {
            "key": "2022011810042072100_B36",
            "doi-asserted-by": "crossref",
            "first-page": "2413",
            "DOI": "10.1093/rfs/hhw069",
            "article-title": "The real effects of lending relationships on innovative firms and inventor mobility",
            "volume": "30",
            "author": "Hombert,",
            "year": "2017",
            "journal-title": "Review of Financial Studies"
        },
        {
            "key": "2022011810042072100_B37",
            "doi-asserted-by": "crossref",
            "first-page": "1136",
            "DOI": "10.1257/aer.20150808",
            "article-title": "Financing innovation: Evidence from r&d grants",
            "volume": "107",
            "author": "Howell,",
            "year": "2017",
            "journal-title": "American Economic Review"
        },
        {
            "issue": "Supplement C",
            "key": "2022011810042072100_B38",
            "doi-asserted-by": "crossref",
            "first-page": "17",
            "DOI": "10.1016/j.jhealeco.2017.01.005",
            "article-title": "Did medicare part d reduce mortality?",
            "volume": "53",
            "author": "Huh,",
            "year": "2017",
            "journal-title": "Journal of Health Economics"
        },
        {
            "key": "2022011810042072100_B39",
            "volume-title": "Concepts and applications of molecular similarity",
            "author": "Johnson,",
            "year": "1990"
        },
        {
            "key": "2022011810042072100_B40",
            "doi-asserted-by": "crossref",
            "first-page": "445",
            "DOI": "10.1146/annurev-financial-111914-041825",
            "article-title": "Financing innovation",
            "volume": "7",
            "author": "Kerr,",
            "year": "2015",
            "journal-title": "Annual Review of Financial Economics"
        },
        {
            "key": "2022011810042072100_B41",
            "doi-asserted-by": "crossref",
            "first-page": "665",
            "DOI": "10.1093/qje/qjw040",
            "article-title": "Technological innovation, resource allocation, and growth",
            "volume": "132",
            "author": "Kogan,",
            "year": "2017",
            "journal-title": "Quarterly Journal of Economics"
        },
        {
            "key": "2022011810042072100_B42",
            "article-title": "Trials and terminations: Learning from competitors\u2019 r&d failures",
            "author": "Krieger,",
            "year": "2020",
            "journal-title": "Management Science"
        },
        {
            "key": "2022011810042072100_B43",
            "doi-asserted-by": "crossref",
            "first-page": "486",
            "DOI": "10.1257/aer.p20171086",
            "article-title": "Is American health care uniquely inefficient? Evidence from prescription drugs",
            "volume": "107",
            "author": "Kyle,",
            "year": "2017",
            "journal-title": "American Economic Review"
        },
        {
            "key": "2022011810042072100_B44",
            "doi-asserted-by": "crossref",
            "first-page": "1433",
            "DOI": "10.1377/hlthaff.2012.0541",
            "article-title": "An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987\u20132011",
            "volume": "32",
            "author": "Lanthier,",
            "year": "2013",
            "journal-title": "Health Affairs"
        },
        {
            "key": "2022011810042072100_B45",
            "doi-asserted-by": "crossref",
            "first-page": "1735",
            "DOI": "10.1377/hlthaff.26.6.1735",
            "article-title": "The impact of medicare part d on prescription drug use by the elderly",
            "volume": "26",
            "author": "Lichtenberg,",
            "year": "2007",
            "journal-title": "Health Affairs"
        },
        {
            "key": "2022011810042072100_B46",
            "doi-asserted-by": "crossref",
            "first-page": "229",
            "DOI": "10.1093/rof/rfr038",
            "article-title": "The effect of financing constraints on risk",
            "volume": "17",
            "author": "Lin,",
            "year": "2013",
            "journal-title": "Review of Finance"
        },
        {
            "key": "2022011810042072100_B47",
            "doi-asserted-by": "crossref",
            "first-page": "3186",
            "DOI": "10.1021/jm401411z",
            "article-title": "Molecular similarity in medicinal chemistry",
            "volume": "57",
            "author": "Maggiora,",
            "year": "2014",
            "journal-title": "Journal of Medicinal Chemistry"
        },
        {
            "key": "2022011810042072100_B48",
            "volume-title": "Patents, citations, and inventive output - evidence from hybrid corn",
            "author": "Moser,",
            "year": "2011"
        },
        {
            "key": "2022011810042072100_B49",
            "doi-asserted-by": "crossref",
            "first-page": "187",
            "DOI": "10.1016/0304-405X(84)90023-0",
            "article-title": "Corporate financing and investment decisions when firms have information that investors do not have",
            "volume": "13",
            "author": "Myers,",
            "year": "1984",
            "journal-title": "Journal of Financial Economics"
        },
        {
            "key": "2022011810042072100_B50",
            "doi-asserted-by": "crossref",
            "first-page": "273",
            "DOI": "10.1016/j.jfineco.2014.07.006",
            "article-title": "Did bank distress stifle innovation during the great depression?",
            "volume": "114",
            "author": "Nanda,",
            "year": "2014",
            "journal-title": "Journal of Financial Economics"
        },
        {
            "key": "2022011810042072100_B51",
            "doi-asserted-by": "crossref",
            "first-page": "1006",
            "DOI": "10.1002/qsar.200330831",
            "article-title": "Approaches to measure chemical similarity\u2014a review",
            "volume": "22",
            "author": "Nikolova,",
            "year": "2004",
            "journal-title": "QSAR & Combinatorial Science"
        },
        {
            "key": "2022011810042072100_B52",
            "doi-asserted-by": "crossref",
            "first-page": "323",
            "DOI": "10.1007/s11306-014-0733-z",
            "article-title": "A \u2018rule of 0.5\u2019 for the metabolite-likeness of approved pharmaceutical drugs",
            "volume": "11",
            "author": "O\u2019Hagan,",
            "year": "2015",
            "journal-title": "Metabolomics"
        },
        {
            "key": "2022011810042072100_B53",
            "volume-title": "Rapid growth in biopharma: Challenges and opportunities",
            "author": "Otto,",
            "year": "2014"
        },
        {
            "key": "2022011810042072100_B54",
            "doi-asserted-by": "crossref",
            "first-page": "5601",
            "DOI": "10.1073/pnas.1614680114",
            "article-title": "Retrospective analysis of natural products provides insights for future discovery trends",
            "volume": "114",
            "author": "Pye,",
            "year": "2017",
            "journal-title": "Proceedings of the National Academy of Sciences"
        },
        {
            "key": "2022011810042072100_B55",
            "article-title": "bbVie bets on Alzheimer\u2019s immunotherapy with big biotech deal",
            "volume-title": "Boston Review",
            "year": "2017"
        },
        {
            "key": "2022011810042072100_B56",
            "doi-asserted-by": "crossref",
            "first-page": "19",
            "DOI": "10.1038/nrd.2017.194",
            "article-title": "Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications",
            "volume": "17",
            "author": "Shih,",
            "year": "2018",
            "journal-title": "Nature Reviews Drug Discovery"
        },
        {
            "key": "2022011810042072100_B57",
            "doi-asserted-by": "crossref",
            "first-page": "391",
            "DOI": "10.2307/2330757",
            "article-title": "The determinants of firms\u2019 hedging policies",
            "volume": "20",
            "author": "Smith,",
            "year": "1985",
            "journal-title": "Journal of Financial and Quantitative Analysis"
        },
        {
            "key": "2022011810042072100_B58",
            "volume-title": "The theory of corporate finance",
            "author": "Tirole,",
            "year": "2010"
        },
        {
            "key": "2022011810042072100_B59",
            "doi-asserted-by": "crossref",
            "first-page": "10911",
            "DOI": "10.1073/pnas.1410933111",
            "article-title": "Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling",
            "volume": "111",
            "author": "Wawer,",
            "year": "2014",
            "journal-title": "Proceedings of the National Academy of Sciences"
        }
    ],
    "container-title": [
        "The Review of Financial Studies"
    ],
    "original-title": [],
    "language": "en",
    "link": [
        {
            "URL": "http://academic.oup.com/rfs/advance-article-pdf/doi/10.1093/rfs/hhab024/37776676/hhab024.pdf",
            "content-type": "application/pdf",
            "content-version": "am",
            "intended-application": "syndication"
        },
        {
            "URL": "https://academic.oup.com/rfs/article-pdf/35/2/636/42228896/hhab024.pdf",
            "content-type": "application/pdf",
            "content-version": "vor",
            "intended-application": "syndication"
        },
        {
            "URL": "https://academic.oup.com/rfs/article-pdf/35/2/636/42228896/hhab024.pdf",
            "content-type": "unspecified",
            "content-version": "vor",
            "intended-application": "similarity-checking"
        }
    ],
    "deposited": {
        "date-parts": [
            [
                2022,
                1,
                18
            ]
        ],
        "date-time": "2022-01-18T10:32:10Z",
        "timestamp": 1642501930000
    },
    "score": 1,
    "resource": {
        "primary": {
            "URL": "https://academic.oup.com/rfs/article/35/2/636/6178014"
        }
    },
    "subtitle": [],
    "editor": [
        {
            "given": "Ralph",
            "family": "Koijen",
            "sequence": "additional",
            "affiliation": []
        }
    ],
    "short-title": [],
    "issued": {
        "date-parts": [
            [
                2021,
                3,
                18
            ]
        ]
    },
    "references-count": 59,
    "journal-issue": {
        "issue": "2",
        "published-online": {
            "date-parts": [
                [
                    2021,
                    3,
                    18
                ]
            ]
        },
        "published-print": {
            "date-parts": [
                [
                    2022,
                    1,
                    18
                ]
            ]
        }
    },
    "URL": "http://dx.doi.org/10.1093/rfs/hhab024",
    "relation": {},
    "ISSN": [
        "0893-9454",
        "1465-7368"
    ],
    "issn-type": [
        {
            "value": "0893-9454",
            "type": "print"
        },
        {
            "value": "1465-7368",
            "type": "electronic"
        }
    ],
    "subject": [
        "Economics and Econometrics",
        "Finance",
        "Accounting"
    ],
    "published-other": {
        "date-parts": [
            [
                2022,
                2,
                1
            ]
        ]
    },
    "published": {
        "date-parts": [
            [
                2021,
                3,
                18
            ]
        ]
    }
}